ArticleProceedings of the National Academy of Sciences of the United States of America2025

Generation of actionable, cancer-specific neoantigens from KRAS(G12C) with adagrasib.

Lorenzo Maso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.